5 Results for "

KRASG12C degrader

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "KRASG12C degrader" in MCE Product Catalog:

Cat. No.: HY-155356
Target:  

PROTACs Ras PERK Akt Caspase

Research Areas:  

Cancer

YN14 is a KRAS G12C PROTAC degrader that recruits E3 ubiquitin ligase to induce the polyubiquitination and proteasomal degradation of KRAS G12C. YN14 induces tumor cell apoptosis, cell cycle arrest, and cell migration inhibition. YN14 exhibits in vivo antitumor proliferative activity in tumor cell xenograft nude mice. YN14 can be used in cancer-related research .
loading...
    loading...
Cat. No.: HY-173252
Research Areas:  

Cancer

KRASG12C ligand-1 is a PROTAC target protein ligand that can be used to synthesize the PROTAC YN14-H (HY-173250). YN14-H is a PROTAC degrader targeting KRAS G12C and has antitumor activity .
loading...
    loading...
Cat. No.: HY-144323
CAS No.: 2913177-53-2
Target:  

PROTACs Ras PERK

Research Areas:  

Cancer

YF135 is a KRAS G12C PROTAC degrader that mediates proteasomal degradation of KRAS G12C in a reversible manner. In KRAS G12C-mutant H358 and H23 lung cancer cells, the DC50 values of YF135 for KRAS degradation are 3.61 μM and 4.53 μM, respectively. YF135 attenuates the pERK signaling pathway in cancer cells. YF135 is applicable for lung cancer-related research .
loading...
    loading...
Cat. No.: HY-175583
CAS No.: 2725905-93-9
Research Areas:  

Cancer

KRASG12C ligand-2 is a KRas ligand used for PROTAC synthesis. KRASG12C ligand-2 serves as the target protein ligand of PROTAC KRAS G12C degrader-2 (HY-153821) .
loading...
    loading...
Cat. No.: HY-155356A
CAS No.: 3053689-54-3
Target:  

PROTACs Ras PERK Akt Caspase

Research Areas:  

Cancer

YN14 mixture of diastereomers is a diastereomer mixture of YN14 (HY-155356). YN14 is a KRAS G12C PROTAC degrader that recruits E3 ubiquitin ligase to induce the polyubiquitination and proteasomal degradation of KRAS G12C. YN14 induces tumor cell apoptosis, cell cycle arrest, and cell migration inhibition. YN14 exhibits in vivo antitumor proliferative activity in tumor cell xenograft nude mice. YN14 can be used in cancer-related research .
loading...
    loading...